Selecting end points in clinical trials: What evidence do we really need to evaluate a new treatment?
- 1 November 2001
- journal article
- Published by Elsevier in American Heart Journal
- Vol. 142 (5) , 745-747
- https://doi.org/10.1067/mhj.2001.119135
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Coronary revascularization without cardiopulmonary bypass in high-risk patients: a route to the futureThe Annals of Thoracic Surgery, 2001
- Off-pump versus on-pump coronary bypass in high-risk subgroupsThe Annals of Thoracic Surgery, 2000
- Transmyocardial Laser RevascularizationNew England Journal of Medicine, 1999
- Transmyocardial Revascularization with a Carbon Dioxide Laser in Patients with End-Stage Coronary Artery DiseaseNew England Journal of Medicine, 1999
- Transmyocardial laser revascularisation compared with continued medical therapy for treatment of refractory angina pectoris: a prospective randomised trialThe Lancet, 1999
- Arthroscopic Treatment of Osteoarthritis of the Knee: A Prospective, Randomized, Placebo-Controlled TrialThe American Journal of Sports Medicine, 1996
- Monitoring the quality of life in patients with coronary artery diseaseThe American Journal of Cardiology, 1994
- Users' Guides to the Medical LiteratureJAMA, 1993
- Measuring Health-Related Quality of LifeAnnals of Internal Medicine, 1993
- Pitfalls in the serial assessment of cardiac functional statusJournal of Chronic Diseases, 1982